Ben Ouyang

Ben Ouyang, B.A.Sc., is an MD/PhD candidate at the University of Toronto. He completed his undergraduate degree in Engineering Science - Biomedical Engineering, also at the University of Toronto. His research interests are in biomaterials and tissue engineering. He has experience in medical device regulatory pathways and is passionate about understanding the human body.

Author's Posts

Exclusive

October 11th, 2019 iRhythm and Verily announced a partnership last month to "co-develop solutions intended to provide early warning, diagnosis and management for patients, particularly for those with silent or undiagnosed AF." We spoke with iRhythm CEO Kevin King to understand how the two companies complement each other and how they can solve the problem...
Exclusive

September 30th, 2019 EchoSens creates non-invasive liver diagnosis medical devices. The company's line of products, called FibroScan, work by measuring the speed of ultrasound waves as they move through liver tissue. This measurement can tell us about the state of the liver. For example, ultrasound waves move faster through fibrotic/scarred livers....
Exclusive

September 4th, 2019 Echosens is a medical device company based in Paris, France that's focused on diagnosing liver disease. Their technology, called FibroScan, uses ultrasonic waves to non-invasively measure the elasticity and absorption of the liver. These measurements can inform medical care teams about the amount of scar tissue and fatty content in...
Exclusive

April 15th, 2019 Deep Lens is an AI-driven digital pathology company based in Ohio. They’re currently working with Worldwide Clinical Trials to fast-track patient enrollment into clinical trials. This week, they announced a successful Series A financing round of $14 million. “Since our inception, we’ve benefited from a tremendous group of...
Exclusive

March 29th, 2019 It doesn't need recalibrating often. The Aktiia optical blood pressure monitor was tested in six healthy volunteers and agreed with a traditional inflating-cuff blood pressure monitor (Omron M6) two months after the initial calibration. The experimental data of this initial study showed error figures within 1 ± 7 mmHg, which are...
Exclusive

March 20th, 2019 Interface Biologics Inc (IBI) is a company from Toronto, Ontario, Canada that develops innovative materials for both Medtech and Pharmaceutical applications. Their Surface Modification Technology is called Endexo, which are fluorine-based additives which migrate to the top 10 nanometers of device surface and prevent platelet adherence...
Society

February 11th, 2019 Health Canada has written a guide for regulating software as medical devices (SaMD). They are now asking for input on their regulations by healthcare professionals, medical device developers, and interested public parties until March 29, 2019. This guidance comes at a great time, given how rapidly software is evolving today and how...
Exclusive

February 6th, 2019 Biomechanics is complex. The body moves in a three-dimensional space, pulling and rotating. We see athletes perform stunning movement combinations on TV in a variety of sports. A basketball player pivots, fades back, and fires a three-pointer. A badminton player jumps, twists, and snaps their arm and racket like a whip onto a...
Society

January 29th, 2019 It's an unprecedented time for innovation and regulation in medical devices. The Food and Drug Administration announced that 2018 was their most successful year in approving medical devices. 106 devices received the FDA's marketing green light, breaking the record of 99 in 2017. These devices included automated insulin dosing...
Next page
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.